Business Context and Reporting Period
Company: Danaher Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2005
Business Overview: Danaher designs, manufactures, and markets industrial and consumer products across three segments: Professional Instrumentation, Industrial Technologies, and Tools & Components. The company utilizes the Danaher Business System (DBS) to drive performance and pursues an acquisition strategy to expand market positions. As of December 31, 2005, the company employed approximately 40,000 people globally.
Key Financial Metrics
| Metric | 2005 | 2004 | 2003 |
|---|---|---|---|
| Sales (Revenue) | $7,984.7 million | $6,889.3 million | $5,293.9 million |
| Operating Profit | $1,264.7 million | $1,105.1 million | $846.0 million |
| Net Earnings | $897.8 million | $746.0 million | $536.8 million |
| Diluted EPS | $2.76 | $2.30 | $1.69 |
| Gross Profit Margin | 43.1% | 42.0% | 40.4% |
| Operating Cash Flow | $1,203.8 million | $1,033.2 million | $861.5 million |
| Total Debt | $1,041.7 million | $1,350.3 million | $1,298.9 million |
| Cash and Equivalents | $315.6 million | $609.1 million | $1,230.2 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated sales increased 16.0% in 2005 compared to 2004. Growth was driven by acquisitions (11.5%) and existing businesses (4.5%), with negligible currency impact.
- Segment Performance:
- Professional Instrumentation: Sales grew 27.5% to $3.78 billion, primarily due to the acquisition of Leica Microsystems and growth in electronic test and environmental businesses. Operating margin decreased to 17.9% from 18.7% due to the dilutive impact of recent acquisitions and restructuring costs.
- Industrial Technologies: Sales grew 11.0% to $2.91 billion. Operating margin improved slightly to 14.7% from 14.6%, despite a $15.5 million litigation settlement charge.
- Tools & Components: Sales declined 1.0% to $1.29 billion, impacted by a divestiture. Operating margin improved to 15.4% from 15.2% due to pricing initiatives and cost reductions.
- Acquisitions: The company spent $885.1 million on acquisitions in 2005, including Leica Microsystems ($429 million) and Linx Printing Technologies ($171 million).
- Debt Reduction: Total debt decreased by approximately $308 million, primarily due to the repayment of $362 million in Eurobond notes at maturity.
Guidance, Outlook, and Risks
- Outlook: Management expects operating margins in dental businesses to improve in 2006 as integration activities take hold. Capital spending for 2006 is expected to be approximately $150 million.
- Dividends: The quarterly dividend was increased to $0.02 per share in September 2005. A dividend of $0.02 per share was declared for payment in January 2006.
- Stock Repurchases: The company repurchased 5 million shares for $257.7 million in 2005. Approximately 5 million shares remain available under the current authorization.
- Risks and Contingencies:
- Subsequent Litigation: A settlement with Federal Express regarding Accu-Sort, Inc. was reached in March 2006. A $15.5 million charge was recorded in 2005 to reflect this subsequent event.
- Environmental Liabilities: The company faces potential liabilities related to past waste disposal practices, particularly at former Joslyn Manufacturing Company sites. Management believes reserves are adequate and liabilities will not have a material adverse effect.
- Acquisition Integration: Risks include the inability to achieve anticipated cost savings or synergies from recent acquisitions, particularly in the medical technologies segment.
Investor Verification Checklist
- Verify the integration progress and margin improvement trajectory of the Leica Microsystems and KaVo acquisitions.
- Monitor the impact of the $15.5 million litigation settlement charge on future legal reserves.
- Assess the sustainability of gross margin expansion (43.1%) amidst rising raw material costs (steel, petroleum).
- Review the status of the $2.1 billion in foreign earnings planned for indefinite reinvestment and potential tax implications of repatriation.
- Track the execution of the remaining $5 million share repurchase authorization.